Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
Michael A. Nauck and David A. D‘Alessio,"Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction",Cardiovascular Diabetology,1475-2840,Springer Science and Business Media LLC,2022-09-01,21,1,169,https://cir.nii.ac.jp/crid/1360584346961896320,https://doi.org/10.1186/s12933-022-01604-7